Amant F - Search Results

1

Prevalent breast cancer patients with a homozygous mutant status for CYP2D6*4: response and biomarkers in tamoxifen users.

Dieudonné AS, Lambrechts D, Claes B, Vandorpe T, Wildiers H, Timmerman D, Billen J, Leunen K, Amant F, Berteloot P, Smeets A, Paridaens R, Weltens C, Van Limbergen E, Van den Bogaert W, Vergote I, Van Huffel S, Christiaens MR, Neven P. Dieudonné AS, et al. Among authors: amant f. Breast Cancer Res Treat. 2009 Dec;118(3):531-8. doi: 10.1007/s10549-009-0463-5. Epub 2009 Jul 12. Breast Cancer Res Treat. 2009. PMID: 19597703

2

Gastrostomy using a "Gastrofix" as an alternative for nasogastric tubes in ovarian cancer surgery.

Amant F, Berteloot P, Vergote I. Amant F, et al. Gynecol Oncol. 1998 Dec;71(3):348-51. doi: 10.1006/gyno.1998.5216. Gynecol Oncol. 1998. PMID: 9887229

3

Subjective assessment of adnexal masses with the use of ultrasonography: an analysis of interobserver variability and experience.

Timmerman D, Schwärzler P, Collins WP, Claerhout F, Coenen M, Amant F, Vergote I, Bourne TH. Timmerman D, et al. Among authors: amant f. Ultrasound Obstet Gynecol. 1999 Jan;13(1):11-6. doi: 10.1046/j.1469-0705.1999.13010011.x. Ultrasound Obstet Gynecol. 1999. PMID: 10201081 Free article.

4

Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial.

Amant F, Spitz B, Timmerman D, Corremans A, Van Assche FA. Amant F, et al. Br J Obstet Gynaecol. 1999 Oct;106(10):1066-70. doi: 10.1111/j.1471-0528.1999.tb08115.x. Br J Obstet Gynaecol. 1999. PMID: 10519433 Clinical Trial.

5

Uterine carcinosarcoma with melanocytic differentiation.

Amant F, Moerman P, Davel GH, De Vos R, Vergote I, Lindeque BG, de Jonge E. Amant F, et al. Int J Gynecol Pathol. 2001 Apr;20(2):186-90. doi: 10.1097/00004347-200104000-00012. Int J Gynecol Pathol. 2001. PMID: 11293166

6

Microsatellite instability in uterine sarcomas.

Amant F, Dorfling CM, Dreyer L, Vergote I, Lindeque BG, Van Rensburg EJ. Amant F, et al. Int J Gynecol Cancer. 2001 May-Jun;11(3):218-23. doi: 10.1046/j.1525-1438.2001.01013.x. Int J Gynecol Cancer. 2001. PMID: 11437928

7

Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations.

Amant F, Dreyer L, Makin J, Vergote I, Lindeque BG. Amant F, et al. Eur J Gynaecol Oncol. 2001;22(3):194-200. Eur J Gynaecol Oncol. 2001. PMID: 11501770

8

Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125.

Amant F, Gabriel C, Timmerman D, Vergote I. Amant F, et al. Gynecol Oncol. 2001 Oct;83(1):153-7. doi: 10.1006/gyno.2001.6251. Gynecol Oncol. 2001. PMID: 11585430

9

Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs' syndrome.

Amant F, Debiec-Rychter M, Schoenmakers EF, Hagemeijer-Hausman A, Vergote I. Amant F, et al. Genes Chromosomes Cancer. 2001 Dec;32(4):324-9. doi: 10.1002/gcc.1197. Genes Chromosomes Cancer. 2001. PMID: 11746973

10

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer.

Vergote I, Amant F, Berteloot P, Van Gramberen M. Vergote I, et al. Among authors: amant f. Int J Gynecol Cancer. 2002 Jan-Feb;12(1):22-6. doi: 10.1046/j.1525-1438.2002.01070.x. Int J Gynecol Cancer. 2002. PMID: 11860532

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

573 results

Search Page